News

Labiotech.eu7d
The future of NSCLC treatment: what’s in store for the therapeutic space?
Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...
Verywell Health on MSN17y
How Chemotherapy for Lung Cancer Works
Medically reviewed by Doru Paul, MD Chemotherapy for lung cancer is used for different purposes depending on the type and ...
pharmaphorum5d
ADRIATIC buoys Imfinzi’s prospects in early lung cancer
After a setback in a trial of Imfinzi in early non-small cell lung cancer (NSCLC) last year, AstraZeneca has clawed back some ground with a positive result in small-cell lung cancer (SCLC), a less ...
Hosted on MSN1mon
EC approves AstraZeneca’s Imfinzi combo for NSCLC
It is a part of a wide development programme, being evaluated as both monotherapy and as conjunction therapy for small cell lung cancer (SCLC), NSCLC, and for gastrointestinal, bladder and breast ...
National Institute for Health and Care Excellence4mon
Treatment for lung cancer
SCLC is an aggressive cancer which spreads at an early stage ... flat cells that line the airways. Surgery for NSCLC has proven to be effective, with National Cancer Registration and Analysis Service ...
Small Cell Lung Cancer Market Expected to rise, 2034 | Ipsen Biopharmaceuticals, BMS, Xcovery Holding Company, EpicentRx, Amgen, expected to rise
The Small Cell Lung Cancer market report also offers comprehensive insights into the Small Cell Lung Cancer market size, ...
PipelineReview.com1d
IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors
SOUTH SAN FRANCISCO, CA, USA I May 6, 2025 I IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and ...